Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM) - update 2012
- 15 August 2012
- journal article
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 21 (1) , 118
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trialThe Lancet, 2011
- Evaluation of predictive models in daily practice for the identification of patients with Lynch syndromeInternational Journal of Cancer, 2011
- Prophylactic surgery in Lynch syndromeTechniques in Coloproctology, 2011
- Calculation of Risk of Colorectal and Endometrial Cancer Among Patients With Lynch SyndromeGastroenterology, 2009
- Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndromeGenes, Chromosomes and Cancer, 2009
- Revised Bethesda Guidelines for Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome) and Microsatellite InstabilityJNCI: Journal of the National Cancer Institute, 2004
- Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis colorectal cancer?Virchows Archiv, 2004
- Prognostic value of Y deletion analysisHuman Reproduction, 2000
- New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative Group on HNPCC☆Gastroenterology, 1999
- A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.1998